您当前的位置：
首页 >
文章列表页 >
Precision medicine in breast cancer in 2025: advances and future directions
更新时间：2026-04-08

    • Precision medicine in breast cancer in 2025: advances and future directions

    • Chin Oncol   Vol. 36, Issue 2, Pages: 110-120(2026)

    • DOI：10.19401/j.cnki.1007-3639.2026.02.003    

      CLC： R737.9

    • Received：09 January 2026，

      Revised：2026-02-09，

      Published：28 February 2026

    移动端阅览

  • WU W, ABUDUREHEIYIMU N, FAN Y, et al. Precision medicine in breast cancer in 2025: advances and future directions［J］. Chin Oncol, 2026, 36(2): 110-120. DOI： 10.19401/j.cnki.1007-3639.2026.02.003.

  •  
  •  

0

Views

83

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

乳腺癌精准治疗的现状与展望
Receptor discordance between primary breast cancer and liver metastases
Progress of important clinical trials of breast cancer in China in 2022
Comparison of clinicopathologic features of breast carcinoma in Shanghai Han and Xinjiang Uygur women
2025 research hotspots and prospects of endocrine therapy for HR+/HER2- breast cancer

Related Author

Precision treatment in breast cancer: current advancements
future directions WU Wei
ABUDUREHEIYIMU Nilupai
FAN Ying
Yizi JIN
Mingxi LIN
Jian ZHANG
Zhibo SHAO

Related Institution

Phase Ⅰ Clinical Trial Center, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University
Department of Breast Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University
Department of Collaborative Innovation Center for Cancer Medicine, Fudan University
复旦大学附属肿瘤医院病理科，复旦大学上海医学院肿瘤学系
新疆医科大学第一附属医院病理科
0